Shiraz Ladiwala
Director/Board Member bei MESA LABORATORIES, INC.
Vermögen: 164 595 $ am 31.03.2024
Profil
Shiraz S.
Ladiwala is currently the Lead Independent Director at Mesa Laboratories, Inc. He previously worked as a Non-Executive Director at Patheon NV.
Before that, he held the position of Senior VP-Business Transformation Projects at Thermo Fisher Scientific, Inc. from 2020 to 2021.
Mr. Ladiwala has an MBA from the University of Michigan and an MBA from the Stephen M.
Ross School of Business.
He also has an undergraduate degree from the University of Mumbai.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MESA LABORATORIES, INC.
0,03% | 01.09.2023 | 1 500 ( 0,03% ) | 164 595 $ | 31.03.2024 |
Aktive Positionen von Shiraz Ladiwala
| Unternehmen | Position | Beginn |
|---|---|---|
| MESA LABORATORIES, INC. | Director/Board Member | 28.10.2021 |
Ehemalige bekannte Positionen von Shiraz Ladiwala
| Unternehmen | Position | Ende |
|---|---|---|
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 31.03.2021 |
| PATHEON N.V. | Director/Board Member | - |
Ausbildung von Shiraz Ladiwala
| University of Michigan | Masters Business Admin |
| University of Mumbai | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MESA LABORATORIES, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Patheon NV
 Patheon NV Pharmaceuticals: MajorHealth Technology Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing. The company was founded on December 24, 2013 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
